Publications by authors named "Yan-Ze Huang"

Article Synopsis
  • The study analyzed data from 36 randomized controlled trials involving nearly 20,000 lung cancer patients to assess the risk of treatment-related adverse events (TRAEs) associated with PD-1/PD-L1 inhibitors.
  • Results indicated that patients using PD-1/PD-L1 inhibitors had a significantly higher likelihood of experiencing all-grade TRAEs, as well as more severe cases, including serious adverse events (SAEs) and fatal adverse events (FAEs).
  • The most common causes of FAEs were found to be respiratory failure/insufficiency, cardiac events, and hematological disorders, highlighting the considerable risks associated with these treatments compared to placebo or supportive care.
View Article and Find Full Text PDF